Live feed08:00:00·36dPRReleaseCoya Therapeutics Announces Publication Demonstrating Regulatory T-Cell Dysfunction and Systemic Inflammation in Frontotemporal Dementia, Supporting Mechanistic Rationale for COYA 302 Immune-Restoring TherapyCOYA· Coya Therapeutics Inc.Health CareOriginal source
